pediatrik yaş grubu çeşitli anemik hastalıkların ayırıcı tanısında ...

76. Carswell EA, Old LJ, Kassel RJ, Green S, Fiore N, Williamson B: An endotoxininduced
serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;
72: 3666-3670.
77. Aggarwal BB, Kohr WJ, Hass PE, et al: Human tumor necrosis factor: Production,
purification and characterization. J Biol Chem 1985; 260: 2345-2354.
78. Nedwin GE, Naylor SL, Sakaguchi AY, et al: Human lymphotoxin and tumor necrosis
factor genes: Structure, homology and chromosomal localization. Nucleic Acids Res
1985; 13: 6361-6373.
79. Cimino G, Amadori S, Cava MC, et al : Serum interleukin-2 (IL-2), soluble IL-2
receptors and tumor necrosis factor-alpha levels are significantly increased in acute
myeloid leukemia patients. Leukemia 1991; 5: 32-35.
80. Balkwill F, Osborne R, Burke F, et al : Evidence for tumor necrosis factor/cachectin
production in cancer. Lancet 1987; 2: 1229-1232.
81. Foa R, Massaia M, Cardona S, et al : Production of tumor necrosis factor-alpha by B-
cell chronic lymphocytic leukemia cells. A possible regulatory role of TNF in the
leukemia cells. A possible regulatory role of TNF in the progression of the disease.
Blood 1990, 76: 393-400.
82. Oster W, Cicco NA, Klein H, et al : Participation of the cytokines interleukin 6, tumor
necrosis factor-alpha, and interleukin 1-β secreted by acute myelogenous leukemia
blasts in autocrine and paracrine leukemia growth control. J Clin Invest 1989; 84: 451-
457.
83. Kobari L, Weil D, Lemoine FM, et al : Secretion of tumor necrosis factor-alpha by
fresh human acute nonlymphoblastic leukemic cells: Role in the disapperance of
normal CFU-GM progenitors. Exp Hematol 1990; 18: 1187-1192.
84. Cuturi MC, Murphy M, Costa-Gione MP, Weinmann R, Perussia B, Trinchieri G :
Independent regulation of tumor necrosis factor and lymphotoxin production by human
peripheral blood lymphocytes. J Exp Med 1987; 165: 1581-1594.
85. Economou JS, McBride WH, Essner R, et al : Tumor necrosis factor production by IL-2
activated macrophages in vitro and in vivo. Immunology 1989; 67: 514-519.
86. Beutler B, Greenwald D, Hulmes JD, et al: Identity of tumor necrosis factor and the
macrophage secreted factor cachectin. Nature 1985, 316: 552-554.
87. Salyer JL, Bohnsack JF, Knape WA, Shigeoka AO, Ashwood ER, Hill HR :
Mechanisms of tumor necrosis factor-alpha. Alteration of PMN adhesion and
migration. Am J Pathol 1990; 136: 831-841.
88. Kehrl JH, Miller A, Fauci AS: Effect of tumor necrosis factor-alpha on mitogenactivated
human B cells. J Exp Med 1987; 166: 786-791.
89. Hellebostad M, Marstrander J, Slrdhl SH, Cotes M, Refsum HE: Serum
immunoreactive erythropoietin in children with acute leukemia at various stages of
disease and the effects of treatment. Eur J Haematol 1990; 44:159.
90. Schrezenmeier H, Noe´ G, Raghavacar A, Rich IN, Heimpel H, Kubanek B: Serum
erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol.
1994; 88:286.
91. Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, Mc- Garigle CJ, Goldberg MA:
Serum erythropoietin levels in patients receiving intensive chemotherapy and
radiotherapy. Blood. 1990;76:2354.
106